Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28010969 | 0.98 | TP53 (0.48) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL28974097 | 0.98 | TP53 (0.48) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL10447282 | 0.98 | TP53 (0.48) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL27615745 | 0.93 | — | — | |
| SCHEMBL27326008 | 0.88 | — | — | |
| SCHEMBL27627523 | 0.86 | — | — | |
| SCHEMBL4683222 | 0.78 | CPN1 (0.36) | TP53SLC6A3DPP4 | |
| SCHEMBL15195460 | 0.77 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL9580015 | 0.77 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL4683701 | 0.77 | CPN1 (0.42) | TP53KDM4ELMNAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3835302-A1 | DIISOCYANATE COMPOUND HAVING ANHYDROSUGAR ALCOHOL CORE AND PREPARATION METHOD THEREFOR | Samyang Corporation (KR) | 2021-06-16 | — | — | EP | disclosed |
| WO-2020032611-A1 | DIISOCYANATE COMPOUND HAVING ANHYDROSUGAR ALCOHOL CORE AND PREPARATION METHOD THEREFOR | 주식회사 삼양사 | 2020-02-13 | — | — | WO | disclosed |
| US-7355061-B2 | Method of manufacturing cyano compounds | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-04-08 | — | — | US | disclosed |
| US-20050004388-A1 | Method of manufacturing cyano compounds | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-01-06 | — | — | US | disclosed |
| US-4247689-A | Preparation of isocyanate derivatives of 1,3[oxazoles, oxazines, diazoles and diazines] | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-27 | — | — | US | disclosed |
| US-4242489-A | Process for preparing polyurethanes | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| US-4173567-A | Isocyanate derivatives of 1,3[oxazoles, oxazines, diazoles and diazines] | BAYER AKTIENGESELLSCHAFT (DE) | 1979-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004388-A1 | Method of manufacturing cyano compounds | HBB, IDH1, NOX3 | TP53 3495/4885KDM4E 3063/4885GMNN 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.